115 related articles for article (PubMed ID: 18340322)
21. Pathways to further boost treatment rates and clinical outcomes in hospitalized stroke patients.
Ovbiagele B
Crit Pathw Cardiol; 2010 Mar; 9(1):8-13. PubMed ID: 20215904
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
23. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
[TBL] [Abstract][Full Text] [Related]
24. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
25. The use of an anesthesia information system to identify and trend gender disparities in outpatient medical management of patients with coronary artery disease.
Vigoda MM; Rodríguez LI; Wu E; Perry K; Duncan R; Birnbach DJ; Lubarsky DA
Anesth Analg; 2008 Jul; 107(1):185-92. PubMed ID: 18635487
[TBL] [Abstract][Full Text] [Related]
26. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery.
Filion KB; Pilote L; Rahme E; Eisenberg MJ
J Card Surg; 2008; 23(3):209-15. PubMed ID: 18435634
[TBL] [Abstract][Full Text] [Related]
27. Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey.
Danchin N; Diévart F; Thébaut JF; Grenier O; Mihci E; Herrmann MA; Ferrières J
Int J Cardiol; 2009 Mar; 133(1):32-40. PubMed ID: 18375000
[TBL] [Abstract][Full Text] [Related]
28. The new heart failure guidelines: strategies for implementation.
O'Connor CM
Am Heart J; 2007 Apr; 153(4 Suppl):2-5. PubMed ID: 17394896
[TBL] [Abstract][Full Text] [Related]
29. Pathways and tools of Stroke PROTECT: a hospital-based recurrent stroke prevention program.
Ovbiagele B
Crit Pathw Cardiol; 2009 Dec; 8(4):151-5. PubMed ID: 19952549
[TBL] [Abstract][Full Text] [Related]
30. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
32. Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program.
Brilakis ES; Hernandez AF; Dai D; Peterson ED; Banerjee S; Fonarow GC; Cannon CP; Bhatt DL
Circulation; 2009 Aug; 120(7):560-7. PubMed ID: 19652090
[TBL] [Abstract][Full Text] [Related]
33. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
34. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.
Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M
J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836
[TBL] [Abstract][Full Text] [Related]
35. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
Wachtel TM; Kucia AM; Greenhill JA
Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
[TBL] [Abstract][Full Text] [Related]
36. UCLA's coronary artery disease initiative begins at the hospital with medication, lifestyle interventions.
Clin Resour Manag; 2001 Jul; 2(7):109-11. PubMed ID: 11482249
[TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapy after myocardial infarction: disease management versus usual care.
Chan V; Cooke CE
Am J Manag Care; 2008 Jun; 14(6):352-8. PubMed ID: 18554073
[TBL] [Abstract][Full Text] [Related]
38. Ensuring management of vascular risk factors after stroke.
Ovbiagele B; Saver JL
Rev Neurol Dis; 2006; 3(3):93-100. PubMed ID: 17047574
[TBL] [Abstract][Full Text] [Related]
39. Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population.
Amin AP; Mukhopadhyay E; Nathan S; Napan S; Kelly RF
Transl Res; 2009 Aug; 154(2):78-89. PubMed ID: 19595439
[TBL] [Abstract][Full Text] [Related]
40. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.
Jhund PS; Macintyre K; Simpson CR; Lewsey JD; Stewart S; Redpath A; Chalmers JW; Capewell S; McMurray JJ
Circulation; 2009 Feb; 119(4):515-23. PubMed ID: 19153268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
